| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Lovins Gregory | SVP and CFO | 8080 NORTON PARKWAY, MENTOR | /s/ Vikas Arora attorney-in-fact for Gregory Lovins | 03 Mar 2026 | 0001701552 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | AVY | Common Stock | Options Exercise | $279,704 | +1,436 | +2% | $194.78 | 73,571 | 01 Mar 2026 | Direct | |
| transaction | AVY | Common Stock | Tax liability | $80,834 | -415 | -0.56% | $194.78 | 73,156 | 01 Mar 2026 | Direct | |
| transaction | AVY | Common Stock | Options Exercise | $224,387 | +1,152 | +1.6% | $194.78 | 74,308 | 01 Mar 2026 | Direct | |
| transaction | AVY | Common Stock | Tax liability | $63,693 | -327 | -0.44% | $194.78 | 73,981 | 01 Mar 2026 | Direct | |
| transaction | AVY | Common Stock | Options Exercise | $167,706 | +861 | +1.2% | $194.78 | 74,842 | 01 Mar 2026 | Direct | |
| transaction | AVY | Common Stock | Tax liability | $47,721 | -245 | -0.33% | $194.78 | 74,597 | 01 Mar 2026 | Direct | |
| transaction | AVY | Common Stock | Options Exercise | $247,371 | +1,270 | +1.7% | $194.78 | 75,867 | 01 Mar 2026 | Direct | |
| transaction | AVY | Common Stock | Tax liability | $70,316 | -361 | -0.48% | $194.78 | 75,506 | 01 Mar 2026 | Direct | |
| transaction | AVY | Common Stock | Options Exercise | $503,312 | +2,584 | +3.4% | $194.78 | 78,090 | 01 Mar 2026 | Direct | |
| transaction | AVY | Common Stock | Tax liability | $207,830 | -1,067 | -1.4% | $194.78 | 77,023 | 01 Mar 2026 | Direct | |
| transaction | AVY | Common Stock | Options Exercise | $1,603,039 | +8,230 | +11% | $194.78 | 85,253 | 01 Mar 2026 | Direct | |
| transaction | AVY | Common Stock | Tax liability | $694,975 | -3,568 | -4.2% | $194.78 | 81,685 | 01 Mar 2026 | Direct | |
| holding | AVY | Common Stock (Savings Plan) | 2,243 | 01 Mar 2026 | Savings Plan |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | AVY | 2026 RSU Award | Award | $0 | +4,329 | $0.000000 | 4,329 | 01 Mar 2026 | Common Stock | 4,329 | $0.000000 | Direct | F1 | |
| transaction | AVY | 2026 PU Award | Award | $0 | +6,259 | $0.000000 | 6,259 | 01 Mar 2026 | Common Stock | 6,259 | $0.000000 | Direct | F2 | |
| transaction | AVY | 2022 MSU Award | Options Exercise | $0 | -1,436 | -100% | $0.000000 | 0 | 01 Mar 2026 | Common Stock | 1,436 | $0.000000 | Direct | F3 |
| transaction | AVY | 2023 MSU Award | Options Exercise | $0 | -1,152 | -50% | $0.000000 | 1,136 | 01 Mar 2026 | Common Stock | 1,152 | $0.000000 | Direct | F4 |
| transaction | AVY | 2024 MSU Award | Options Exercise | $0 | -861 | -32% | $0.000000 | 1,805 | 01 Mar 2026 | Common Stock | 861 | $0.000000 | Direct | F5 |
| transaction | AVY | 2025 MSU Award | Options Exercise | $0 | -1,270 | -24% | $0.000000 | 3,971 | 01 Mar 2026 | Common Stock | 1,270 | $0.000000 | Direct | F6 |
| transaction | AVY | 2023 PU Award | Options Exercise | $0 | -2,584 | -100% | $0.000000 | 0 | 01 Mar 2026 | Common Stock | 2,584 | $0.000000 | Direct | F7 |
| transaction | AVY | 2023 RSU Award | Options Exercise | $0 | -8,230 | -100% | $0.000000 | 0 | 01 Mar 2026 | Common Stock | 8,230 | $0.000000 | Direct | F8 |
| Id | Content |
|---|---|
| F1 | Restricted stock units (RSUs) vest 25% on each of the first, second, third and fourth anniversaries of the grant date. Each RSU represents a contingent right to receive one share of common stock. |
| F2 | Performance units (PUs) vest, at the end of fiscal year 2028, provided certain performance objectives are met as determined by the Compensation Committee in February 2029. Each PU represents a contingent right to receive one share of common stock. |
| F3 | Shares reflect the vesting of the fourth tranche of MSUs granted in February 2022 at 92% of target based on our absolute total stockholder return in excess of 10% during the 2022-2025 performance period, plus dividend equivalents accrued during the period. |
| F4 | Shares reflect the vesting of the third tranche of MSUs granted in March 2023 at 96% of target based on our absolute total stockholder return during the 2023-2025 performance period, plus dividend equivalents accrued during the period. |
| F5 | Shares reflect the vesting of the second tranche of MSUs granted in March 2024 at 92% of target based on our absolute total stockholder return during the 2024-2025 performance period, plus dividend equivalents accrued during the period. |
| F6 | Shares reflect the vesting of the first tranche of MSUs granted in March 2025 at 94% of target based on our absolute total stockholder return during the 2025 performance period, plus dividend equivalents accrued during the period. |
| F7 | Shares reflect the vesting of PUs granted in March 2023 at 56% of target, based 50% on our cumulative economic value added of 0% of target and 50% on our relative total stockholder return of 112% of target. |
| F8 | Shares reflect the vesting of RSUs granted on March 1, 2023 which cliff-vest on the third anniversary of the grant date. |